Biocryst Pharmaceuticals Inc. - BCRX - stock price prediction, stock price target, analyst ratings from 10 analysts

Biocryst Pharmaceuticals Inc. has a share price target of US$ 17, revenue growth forecast of 35.1%, and profit growth estimate of 130.8% for FY25, based on top 10 analyst calls.